Technical Analysis for XRTX - Xortx Therapeutics Inc

Grade Last Price % Change Price Change
D 2.0 -3.85% -0.080
XRTX closed down 0.95 percent on Thursday, January 27, 2022, on 49 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical XRTX trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness -3.85%
Wide Bands Range Expansion -3.85%
Lower Bollinger Band Touch Weakness -3.85%
Oversold Stochastic Weakness -3.85%
Lower Bollinger Band Walk Weakness -4.76%
Wide Bands Range Expansion -4.76%
Lower Bollinger Band Touch Weakness -4.76%
Oversold Stochastic Weakness -4.76%
New 52 Week Closing Low Bearish -0.50%
Lower Bollinger Band Walk Weakness -0.50%
Older End-of-Day Signals for XRTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 2 hours ago
Down 2% about 2 hours ago
Down 1% about 2 hours ago
Gapped Up (Full) 8 days ago
Rose Above Previous Day's High 8 days ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Xortx Therapeutics Inc Description

XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, hypertension, insulin resistance, and diabetic nephropathy. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and suppression of acute kidney injury and associated health consequences; and XRx-221, a xanthine oxidase inhibitor candidates for the treatment of diabetic nephropathy. The company has a partnership with the Icahn School of Medicine to study the incidence of acute kidney injury and hyperuricemia in patients hospitalized with COVID-19. XORTX Therapeutics Inc. is headquartered in Vancouver, Canada.


Sector: Healthcare
Industry: Biotechnology
Keywords: Medical Specialties Infection Organ Systems Diabetes Hypertension Kidney Disease

Is XRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 4.49
52 Week Low 1.9
Average Volume 16,588
200-Day Moving Average 0.000
50-Day Moving Average 2.646
20-Day Moving Average 2.357
10-Day Moving Average 2.193
Average True Range 0.199
ADX 19.53
+DI 16.672
-DI 24.426
Chandelier Exit (Long, 3 ATRs) 2.155
Chandelier Exit (Short, 3 ATRs) 2.496
Upper Bollinger Bands 2.766
Lower Bollinger Band 1.947
Percent B (%b) 0.16
BandWidth 34.789
MACD Line -0.180
MACD Signal Line -0.169
MACD Histogram -0.0112
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.350
Resistance 3 (R3) 2.320 2.200 2.305
Resistance 2 (R2) 2.200 2.131 2.215 2.290
Resistance 1 (R1) 2.140 2.089 2.170 2.170 2.275
Pivot Point 2.020 2.020 2.035 2.035 2.020
Support 1 (S1) 1.960 1.951 1.990 1.990 1.885
Support 2 (S2) 1.840 1.909 1.855 1.870
Support 3 (S3) 1.780 1.840 1.855
Support 4 (S4) 1.810